In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists for four decades: it reliably produced potent, virus-blocking antibodies in most participants. The work, published last week in Science Translational Medicine, tested three experimental vaccines built with the same mRNA technology used in COVID-19 shots but with a …
Read More »This mRNA HIV Vaccine Produces the Virus-Fighting Antibodies That Have Eluded Researchers for 40 Years
